We are live on
!
Find out more
SGA
Sector Gamma AS Portfolio holdings
AUM
$461M
1-Year Est. Return
33.26%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+33.26%
3 Year Est. Return
+35.29%
5 Year Est. Return
+56.36%
10 Year Est. Return
+229.32%
AUM
$417M
AUM Growth
+$46.4M
(+13%)
Cap. Flow
+$20M
Cap. Flow
% of AUM
4.81%
Top 10 Holdings %
Top 10 Hldgs %
59.21%
Holding
39
New
6
Increased
14
Reduced
10
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$22.4M |
| 2 |
Baxter International
BAX
|
+$16.2M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$12.6M |
| 4 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
+$10.2M |
| 5 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$8.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$26.4M |
| 2 |
Boston Scientific
BSX
|
+$7.67M |
| 3 |
MASI
Masimo
MASI
|
+$7.11M |
| 4 |
STJ
St Jude Medical
STJ
|
+$6.57M |
| 5 |
Cardinal Health
CAH
|
+$6.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.01% |
| 2 | Miscellaneous | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
United Therapeutics
UTHR
$20.9B
| $5.88M | 1.41% |
62,510
+23,600
| +61% | +$2.41M |
|
27
Integra LifeSciences
IART
$1.3B
| $4.18M | 1% |
222,629
+48,929
| +28% | +$944K |
|
|
MDCO
28
DELISTED
Medicines Co
MDCO
| $3.63M | 0.87% |
127,550
-160,300
| -56% | -$5.3M |
|
|
CTRX
29
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $2.69M | 0.64% |
+60,000
| New | +$2.89M |
|
|
SPPI
30
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $392K | 0.09% |
50,000
| – | – |
|
|
VVUS
31
DELISTED
Vivus Inc
VVUS
| $238K | 0.06% |
+4,000
| New | +$284K |
|
32
Biogen
BIIB
$32.6B
| – | – |
-20,000
| Closed | -$5.59M |
|
|
MASI
33
DELISTED
Masimo
MASI
| – | – |
-243,150
| Closed | -$7.11M |
|
|
ACH
34
Accendra Health
ACH
$93.1M
| – | – |
-80,084
| Closed | -$2.93M |
|
|
MNTA
35
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| – | – |
-136,800
| Closed | -$2.42M |
|
|
STJ
36
DELISTED
St Jude Medical
STJ
| – | – |
-106,000
| Closed | -$6.57M |
|
|
HNT
37
DELISTED
HEALTH NET INC
HNT
| – | – |
-145,000
| Closed | -$4.3M |
|
|
FRX
38
DELISTED
FOREST LABORATORIES INC
FRX
| – | – |
-440,349
| Closed | -$26.4M |
|
|
AGN
39
DELISTED
Allergan Inc
AGN
| – | – |
-45,000
| Closed | -$5M |
|
Similar funds
IAG
PAA
PC
HIP
UCI
JC
BCM
GIM
Sector Gamma AS's Q1 2014 Portfolio in Review
As of Q1 2014, Sector Gamma AS held 39 positions worth $417M, up 13% from $371M the previous quarter. Its ten largest holdings account for 59% of the portfolio.
Sector Gamma AS deployed $20M of net new capital in Q1 2014, opening 6 new positions and adding to 14 existing holdings. Its largest new stake was AbbVie: 443,400 shares worth $22.8M.
By sector, the portfolio is most concentrated in Healthcare at 89% of assets, down from 91% a quarter earlier, followed by Miscellaneous.
On the sell side, the largest reduction was Boston Scientific, an estimated $7.67M trimmed.
- Sector Gamma AS's largest Q1 2014 buy was AbbVie: 443,400 shares worth $22.8M.
- Sector Gamma AS added most to Baxter International in Q1 2014, an estimated $16.2M increase.
- Sector Gamma AS's biggest Q1 2014 reduction was Boston Scientific, cutting an estimated $7.67M.
- Sector Gamma AS fully exited FOREST LABORATORIES INC in Q1 2014, selling an estimated $26.4M.
- Sector Gamma AS's ten largest holdings make up 59% of its $417M portfolio in Q1 2014.
- Sector Gamma AS opened 6 new positions and closed 8 in Q1 2014.
- Sector Gamma AS's portfolio value rose 13% quarter-over-quarter to $417M.
Based on Sector Gamma AS's 13F filing for Q1 2014, filed 9 May 2014.